Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 85.83
-0.91 (-1.05%)
At close: Dec 23, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 19.82 billion as of December 23, 2025. Its market cap has increased by 73.83% in one year.
Market Cap
19.82B
Enterprise Value
21.71B
Revenue
13.30B
Ranking
n/a
PE Ratio
22.18
Stock Price
85.83
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 19.82B, an increase of 177.37%. That is a compound annual growth rate of 25.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 19.82B | 27.35% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 123.19B |
| Abbott Laboratories (Pakistan) | 102.81B |
| The Searle Company | 64.35B |
| Highnoon Laboratories | 53.85B |
| AGP Limited | 53.24B |
| Shifa International Hospitals | 31.92B |
| Ferozsons Laboratories | 16.02B |
| Macter International | 15.47B |